~~<i id='026C789FF9'><strike id='026C789FF9'><tt id='026C789FF9'><pre id='026C789FF9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：focus 2025-09-29 01:09:34 - browse：53

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Big Tobacco's 'harm reduction': Is it for real, or a sham?

hotspot

focus

leisure time

entertainment

hotspot

Neurons(red)andastrocytes(green)derivedfromhumanneuralstemcellsgrowinginculture.StevenPollard/Wellco

WSS

Update the Apgar Score to remove skin color

Wearables generate powerful data but its not useful to doctors, yet

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Inaction leaves children at risk from dangerous chemotherapy drug

Criminal prosecution for violating HIPAA: an emerging threat

Future doctors need a strong humanities education

leisure time

fashion

hotspot

Virginia high school admissions case could be legal follow

Readers respond to H5N1 and livestock movements, and more

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Helping hospitals and community health centers plan for resilience

Continuity nursing helped my family in our darkest PICU moments

With measles on the rise, a personal story of a devastating disease

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Military medical care influenced by rank and race, new study finds

hotspot

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

FDA sets aggressive timeline for overhauling inspection procedures

Cytokinetics CEO stresses company can launch heart drug on its own

What causes osteoarthritis? Researchers study link to brain protein

Future doctors need a strong humanities education

Head of FDA's diagnostics center, who led through Covid, retires

focus

leisure time

entertainment

hotspot